Baker Avenue Asset Management »

Sarepta Therapeutics shares owned by Baker Avenue Asset Management

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Baker Avenue Asset Management from 13F filings

Historical chart of Baker Avenue Asset Management investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Baker Avenue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Baker Avenue Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 62k 19.27
2023-09-30 $5.6k 46 121.22
2023-06-30 $5.3k 46 114.52
2023-03-31 $6.3k 46 137.83
2022-12-31 $6.0k 46 129.59

More positions owned by Baker Avenue Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Simpson Manufacturing (SSD)
Vanguard Index Fds Small Cp Etf (VB)
Oracle Corporation (ORCL)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Spdr Series Trust Portfolio Agrgte (SPAB)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)
Vanguard Index Fds Large Cap Etf (VV)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)

View all positions for Baker Avenue Asset Management

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Susquehanna International
Erste Asset Management GmbH
Renaissance Technologies
Two Sigma Investments
D. E. Shaw & Co
UBS Group
Standard Life Aberdeen
Two Sigma Advisers
First Trust Advisors
Citadel Advisors
Bnp Paribas Arbitrage, Snc
Connor, Clark & Lunn Investment Management

View all funds holding Sarepta Therapeutics